| Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial N Dizman, L Meza, P Bergerot, M Alcantara, T Dorff, Y Lyou, P Frankel, ... Nature Medicine, 1-9, 2022 | 227 | 2022 |
| Circulating cytokines associated with clinical response to systemic therapy in metastatic renal cell carcinoma A Chehrazi-Raffle, L Meza, M Alcantara, N Dizman, P Bergerot, N Salgia, ... Journal for immunotherapy of cancer 9 (3), 2021 | 29 | 2021 |
| Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell … MS Ernst, V Navani, JC Wells, F Donskov, N Basappa, C Labaki, SK Pal, ... European Urology, 2023 | 22 | 2023 |
| Outcomes of patients with advanced non-clear cell renal cell carcinoma treated with first-line immune checkpoint inhibitor therapy J Graham, JC Wells, S Dudani, CL Gan, F Donskov, J Lee, ... European Journal of Cancer 171, 124-132, 2022 | 18 | 2022 |
| Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma ZB Zengin, A Chehrazi-Raffle, NJ Salgia, R Muddasani, S Ali, L Meza, ... Urologic Oncology: Seminars and Original Investigations, 2021 | 17 | 2021 |
| Targeted therapy and immunotherapy: effect of body mass index on clinical outcomes in patients diagnosed with metastatic renal cell carcinoma PG Bergerot, CD Bergerot, EJ Philip, L Meza, N Dizman, JA Hsu, SK Pal Kidney Cancer 3 (1), 63-70, 2019 | 17 | 2019 |
| Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma V Navani, M Ernst, JC Wells, T Yuasa, K Takemura, F Donskov, ... JAMA Network Open 5 (6), e2216379-e2216379, 2022 | 14 | 2022 |
| CABOSEQ: The effectiveness of cabozantinib in patients with treatment refractory advanced renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma … V Navani, JC Wells, DJ Boyne, WY Cheung, DM Brenner, BA McGregor, ... Clinical Genitourinary Cancer, 2022 | 12 | 2022 |
| Complementary role of circulating tumor DNA assessment and tissue genomic profiling in metastatic renal cell carcinoma ZB Zengin, C Weipert, NJ Salgia, N Dizman, J Hsu, L Meza, ... Clinical Cancer Research 27 (17), 4807-4813, 2021 | 12 | 2021 |
| First results of a randomized phase IB study comparing nivolumab/ipilimumab with or without CBM-588 in patients with metastatic renal cell carcinoma. LA Meza, N Dizman, PG Bergerot, TB Dorff, Y Lyou, PH Frankel, V Mira, ... Journal of Clinical Oncology 39 (15_suppl), 4513-4513, 2021 | 12 | 2021 |
| Effect of CBM588 in combination with cabozantinib plus nivolumab for patients (pts) with metastatic renal cell carcinoma (mRCC): A randomized clinical trial. H Ebrahimi, LA Meza, K Lee, J Malhotra, M Alcantara, ZB Zengin, ... Journal of Clinical Oncology 41 (17_suppl), LBA104-LBA104, 2023 | 8 | 2023 |
| Cytoreductive nephrectomy in 2021: obsolete L Meza, NS Chawla, G Giannarini, SK Pal European Urology Open Science 36, 44-46, 2022 | 8 | 2022 |
| Is there a role for novel TKI/ICI combinations in metastatic renal cell carcinoma? Definitely maybe L Meza, PG Bergerot, N Agarwal, SK Pal Annals of Oncology 32 (1), 12-14, 2021 | 8 | 2021 |
| Genomic and clinical prognostic factors in patients with advanced urothelial carcinoma receiving immune checkpoint inhibitors NS Chawla, N Sayegh, N Tripathi, A Govindarajan, ZB Zengin, EJ Phillip, ... Clinical Genitourinary Cancer, 2022 | 7 | 2022 |
| Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell … CL Gan, J Huang, E Pan, W Xie, AL Schmidt, C Labaki, L Meza, ... European Urology Oncology, 2022 | 6 | 2022 |
| Association between time-of-day of immune checkpoint blockade administration and outcomes in metastatic renal cell carcinoma N Dizman, A Govindarajan, ZB Zengin, L Meza, N Tripathi, N Sayegh, ... Clinical Genitourinary Cancer, 2023 | 5 | 2023 |
| Outcomes of patients with brain metastases from renal cell carcinoma treated with first-line therapies: Results from the International Metastatic Renal Cell Carcinoma Database … K Takemura, A Lemelin, MS Ernst, C Wells, NS Basappa, B Szabados, ... Journal of Clinical Oncology 41 (6_suppl), 600-600, 2023 | 5 | 2023 |
| The Gut Microbiome and Metastatic Renal Cell Carcinoma L Meza, M Feng, K Lee, R Sperandio, SK Pal Journal of Clinical Medicine 12 (4), 1502, 2023 | 5 | 2023 |
| CABOSEQ: The efficacy of cabozantinib post up-front immuno-oncology combinations in patients with advanced renal cell carcinoma: Results from the International Metastatic Renal … V Navani, C Wells, DJ Boyne, WY Cheung, D Brenner, BA McGregor, ... Journal of Clinical Oncology 40 (6_suppl), 318-318, 2022 | 5 | 2022 |
| Cabozantinib plus immunotherapy combinations in metastatic renal cell and urothelial carcinoma L Meza, J Malhotra, C Favorito, SK Pal Future Oncology 18 (1), 21-33, 2021 | 5 | 2021 |
Sumanta PalCity of HopeVerified email at coh.org
